Toronto Dominion Bank grew its position in Centene Corp (NYSE:CNC) by 13.6% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 74,295 shares of the company’s stock after purchasing an additional 8,880 shares during the period. Toronto Dominion Bank’s holdings in Centene were worth $7,495,000 as of its most recent filing with the SEC.
Several other large investors have also recently modified their holdings of the company. New Mexico Educational Retirement Board boosted its stake in shares of Centene by 3.8% in the 4th quarter. New Mexico Educational Retirement Board now owns 16,600 shares of the company’s stock valued at $1,675,000 after purchasing an additional 600 shares in the last quarter. Carnick & Kubik Group LLC acquired a new position in Centene during the 4th quarter worth about $3,622,000. Pegasus Partners Ltd. lifted its position in Centene by 39.3% during the 4th quarter. Pegasus Partners Ltd. now owns 17,257 shares of the company’s stock worth $1,741,000 after buying an additional 4,870 shares in the last quarter. Penserra Capital Management LLC lifted its position in Centene by 211.0% during the 4th quarter. Penserra Capital Management LLC now owns 54,568 shares of the company’s stock worth $5,504,000 after buying an additional 37,023 shares in the last quarter. Finally, AGF Investments Inc. acquired a new position in Centene during the 4th quarter worth about $49,577,000. Institutional investors own 90.53% of the company’s stock.
Centene Corp (CNC) opened at $101.67 on Wednesday. The company has a current ratio of 0.93, a quick ratio of 0.93 and a debt-to-equity ratio of 0.68. The stock has a market cap of $17,579.84, a PE ratio of 19.94, a price-to-earnings-growth ratio of 0.97 and a beta of 0.76. Centene Corp has a 52-week low of $65.03 and a 52-week high of $112.42.
CNC has been the topic of several research reports. Jefferies Group upped their price target on shares of Centene from $112.00 to $115.00 and gave the stock a “buy” rating in a research report on Monday, December 18th. Piper Jaffray Companies reiterated a “buy” rating and set a $134.00 price target on shares of Centene in a research report on Monday, December 18th. Cantor Fitzgerald reiterated a “buy” rating and set a $115.00 price target on shares of Centene in a research report on Monday, December 18th. Oppenheimer reiterated a “buy” rating and set a $111.00 price target on shares of Centene in a research report on Friday, December 15th. Finally, ValuEngine upgraded shares of Centene from a “hold” rating to a “buy” rating in a research report on Friday, February 2nd. Three research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the company. Centene has an average rating of “Buy” and an average price target of $110.28.
In other news, EVP Christopher D. Bowers sold 4,800 shares of the company’s stock in a transaction dated Monday, March 12th. The stock was sold at an average price of $102.27, for a total value of $490,896.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Robert K. Ditmore sold 8,750 shares of the company’s stock in a transaction dated Thursday, February 8th. The shares were sold at an average price of $104.13, for a total value of $911,137.50. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 37,300 shares of company stock valued at $3,802,509. 3.00% of the stock is currently owned by company insiders.
TRADEMARK VIOLATION NOTICE: This news story was originally published by Week Herald and is the sole property of of Week Herald. If you are reading this news story on another site, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright legislation. The legal version of this news story can be accessed at https://weekherald.com/2018/03/14/centene-corporation-cnc-position-boosted-by-toronto-dominion-bank.html.
Centene Corporation is a healthcare company. The Company provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. The Company operates through two segments: Managed Care and Specialty Services. The Company’s Managed Care segment provides health plan coverage to individuals, through government subsidized programs, including Medicaid, the State Children’s Health Insurance Program (CHIP), Long Term Care, Foster Care, dual-eligible individuals (Duals) and the Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program (ABD), Medicare, and Health Insurance Marketplace.
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.